Inventor
MARTINEZ-SOBRIDO LUIS
US13 patents
Patents
13 patentsUS11576963B2Feb 14, 2023
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses
UNIV ROCHESTER2 citations69
US10342861B2Jul 9, 2019
Arenavirus vaccine
UNIV ROCHESTER2 citations69
US10478489B2Nov 19, 2019
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
UNIV ROCHESTER3 citations68
US9943585B2Apr 17, 2018
Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV)
UNIV ROCHESTER4 citations68
US12516108B2Jan 6, 2026
Monoclonal antibodies against the hemagglutinin (HA) and neuraminidase (NA) of in-fluenza H3N2 viruses
UNIV ROCHESTER1 citations58
US12350328B2Jul 8, 2025
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses
UNIV ROCHESTER0 citations58
US11065326B2Jul 20, 2021
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
UNIV ROCHESTER0 citations57
US10973903B2Apr 13, 2021
NS1 truncated virus for the development of canine influenza vaccines
UNIV ROCHESTER0 citations57
US12421301B2Sep 23, 2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof
UNIV ROCHESTER0 citations56
US11958895B2Apr 16, 2024
Anti-influenza neuraminidase monoclonal antibodies and uses thereof
UNIV ROCHESTER0 citations56
US11168129B2Nov 9, 2021
Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof
UNIV ROCHESTER1 citations55
US10857224B2Dec 8, 2020
Equine influenza virus live attenuated vaccines
UNIV ROCHESTER0 citations50
US10548966B2Feb 4, 2020
Single-cycle virus for the development of canine influenza vaccines
UNIV ROCHESTER0 citations47